ZIVO Bioscience Overview
- Founded
- 2003
- Status
- Public
- Employees
- 7
- Stock Symbol
- ZIVO
- Investments
- 2
- Share Price
- $0.11
- (As of Thursday Closing)
ZIVO Bioscience General Information
Description
Zivo Bioscience Inc is a biotechnology company that is engaged in selling natural bioactive ingredients derived from proprietary algae cultures to an animal, human and dietary supplement and medical food manufacturers. The company focuses on research and identification of its bioactive ingredients. It also develops tests that allow people to optimize their health and identify future health risks. The company's product candidate ZIVO algae strain is a human dietary supplement that acts as a source of non-animal nutrition, animal supplement, and livestock feed additive, boosting productivity and overall health. Its other product categories are animal applications, human applications, functional food ingredient, dietary supplements and nutraceuticals, and medical food and Botanical Drug.
Contact Information
Website
Formerly Known As
Health Enhancement Products, Health Enhancement
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Biotechnology
Stock Exchange
PINX
Primary Office
- 2804 Orchard Lake Road
- Suite 202
- Keego Harbor, MI 48320
- United States
+1 (248) 000-0000
ZIVO Bioscience Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.11 | $0.11 | $0.05 - $0.17 | $43.9M | 407M | 41.7K | -$0.04 |
ZIVO Bioscience Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2020 | FY 2019 31-Dec-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 |
|---|---|---|---|---|
| EV | 49,296 | 66,639 | 39,638 | 29,285 |
| Revenue | 20 | 0 | 0 | 0 |
| EBITDA | (9,349) | (8,352) | (6,538) | (7,071) |
| Net Income | (9,623) | (11,510) | (14,635) | (10,038) |
| Total Assets | 223 | 369 | 412 | 332 |
| Total Debt | 5,353 | 5,280 | 18,155 | 13,960 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
ZIVO Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore ZIVO Bioscience‘s full profile, request access.
Request a free trialZIVO Bioscience Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Andrew Dahl | Chief Executive Officer & President | ||
| Philip Rice II | Chief Financial Officer, Finance & Board Member |
ZIVO Bioscience Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 00000 | Self | Board Member | 000 0000 |
| 000000 0000 00 | ZIVO Bioscience | Chief Financial Officer, Finance & Board Member | 000 0000 |
ZIVO Bioscience Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialZIVO Bioscience Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore ZIVO Bioscience‘s full profile, request access.
Request a free trialZIVO Bioscience Acquisitions (2)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 000000000 | 26-Aug-2013 | 000000000000000000 | 00.00 | Asset Management | 000000 0000 |
| Wellness Indicators | 22-Aug-2013 | Merger/Acquisition | Monitoring Equipment |